Safety concerns, patent and affordability issues collide The FDA has warned about potentially substandard quality, unlabeled salt forms, and dosing errors in compounded versions
Compounded formulations may use different excipient profiles than brand-name products
Interact with neuroendocrine pathways to influence motility and secretion
Because creating glutathione and fighting ROS is highly energy-dependent, the immune system consumes massive amounts of the host's ATP
Full side effect data from TRIUMPH-1 has since been presented at the ADA 86th Scientific Sessions (June 6, 2026): nausea 42.4%, diarrhea 32.0%, vomiting 25.3%, and dysesthesia 12.5% at 12mg
10.1186/s12967-025-06341-5 59 XuL.ChangC.JiangP.WeiK.ZhangR.JinY.et al (2022)